BBH
VanEck Biotech ETF
Price Chart
Latest Quote
$188.10
+0.04 (+0.02%)
Current Price
| Previous Close | $188.06 |
| Open | $188.94 |
| Day High | $190.33 |
| Day Low | $188.10 |
| Volume | 4,286 |
Fund Information
| Quarterly Dividend / Yield | N/A / 0.51% |
| Net Assets | $366.87M |
| Expense Ratio | 0.35% |
| Category | Health |
| Fund Family | VanEck |
| Net Asset Value | $187.96 |
| Premium/Discount | 0.07% |
| Quarterly Dividend Yield | 0.51% |
| P/E Ratio | 23.37 |
| Exchange | NGM |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $186.22 |
| SMA50 | $186.83 |
| SMA200 | $185.51 |
| RSI | 49.72 |
| ATR | 2.9284 |
| Rel Volume | 1.21 |
Performance History
| Week | +2.74% |
| Month | +4.56% |
| Quarter | +2.16% |
| 6 Months | -1.08% |
| YTD | -1.12% |
| Year | +22.13% |
| 3 Years | +20.34% |
| 5 Years | -4.09% |
| 10 Years | +92.35% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $188.10 | 4,286 |
| 2026-06-16 | $187.97 | 2,500 |
| 2026-06-15 | $188.13 | 3,500 |
| 2026-06-12 | $187.56 | 2,800 |
| 2026-06-11 | $187.88 | 6,200 |
| 2026-06-10 | $183.08 | 3,200 |
| 2026-06-09 | $187.49 | 3,900 |
| 2026-06-08 | $186.05 | 3,500 |
| 2026-06-05 | $188.00 | 2,800 |
| 2026-06-04 | $189.49 | 2,300 |
| 2026-06-03 | $185.77 | 1,800 |
| 2026-06-02 | $181.73 | 5,400 |
| 2026-06-01 | $185.94 | 5,300 |
| 2026-05-29 | $188.64 | 2,700 |
| 2026-05-28 | $188.27 | 2,500 |
| 2026-05-27 | $184.68 | 6,600 |
| 2026-05-26 | $183.98 | 2,100 |
| 2026-05-22 | $184.76 | 1,900 |
| 2026-05-21 | $184.03 | 2,700 |
| 2026-05-20 | $182.86 | 4,700 |
| 2026-05-19 | $181.12 | 6,600 |
| 2026-05-18 | $179.90 | 9,200 |
About VanEck Biotech ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
đ° Latest News
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
Zacks âĸ 2026-06-10T16:00:00Z
Should You Invest in the VanEck Biotech ETF (BBH)?
Zacks âĸ 2026-05-11T10:20:01Z
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM
Zacks âĸ 2026-03-17T09:05:00Z
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave
Zacks âĸ 2026-03-16T13:39:00Z
BBH- A Biotech Fund That's Ripe for a Major Turnaround
MoneyShow âĸ 2025-08-04T05:01:00Z
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.